These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1762106)

  • 41. [Epidemiological studies on thyroid cancer in Nagasaki City].
    Jubashi T; Matsuo T; Shimokawa I; Wago M; Ikeda T
    Gan No Rinsho; 1984 May; 30(5):459-65. PubMed ID: 6727045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose.
    Takahashi K; Eguchi H; Arihiro K; Ito R; Koyama K; Soda M; Cologne J; Hayashi Y; Nakata Y; Nakachi K; Hamatani K
    Mol Carcinog; 2007 Mar; 46(3):242-8. PubMed ID: 17186541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
    Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid carcinoma after exposure to atomic radiation. A continuing survey of a fixed population, Hiroshima and Nagasaki, 1958-1971.
    Parker LN; Belsky JL; Yamamoto T; Kawamoto S; Keehn RJ
    Ann Intern Med; 1974 May; 80(5):600-4. PubMed ID: 4823811
    [No Abstract]   [Full Text] [Related]  

  • 46. Radiation dose response estimation with emphasis on low dose range using restricted cubic splines: application to all solid cancer mortality data, 1950-2003, in atomic bomb survivors.
    Nakashima E
    Health Phys; 2015 Jul; 109(1):15-24. PubMed ID: 26011495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Tumor registries and cancer incidence studies.
    Mabuchi K; Soda M
    J Radiat Res; 1991 Mar; 32 Suppl():239-44. PubMed ID: 1762111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation.
    Shimizu Y; Schull WJ; Kato H
    JAMA; 1990 Aug; 264(5):601-4. PubMed ID: 2366300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980.
    Tokunaga M; Land CE; Yamamoto T; Asano M; Tokuoka S; Ezaki H; Nishimori I
    Radiat Res; 1987 Nov; 112(2):243-72. PubMed ID: 3685255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid cancers in atomic bomb survivors exposed in youth: 30-year follow-up study.
    Taher MA
    J Nucl Med; 1988 Feb; 29(2):268-9. PubMed ID: 3346738
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ
    Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parathyroid tumors in atomic bomb survivors in Hiroshima: epidemiological study from registered cases at Hiroshima Prefecture Tumor Tissue Registry, 1974-1987.
    Takeichi N; Dohi K; Yamamoto H; Ito H; Mabuchi K; Yamamoto T; Shimaoka K; Yokoro K
    Jpn J Cancer Res; 1991 Aug; 82(8):875-8. PubMed ID: 1910024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer.
    Land CE
    JAMA; 1995 Aug; 274(5):402-7. PubMed ID: 7616636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer risk among children of atomic bomb survivors. A review of RERF epidemiologic studies. Radiation Effects Research Foundation.
    Yoshimoto Y
    JAMA; 1990 Aug; 264(5):596-600. PubMed ID: 2366299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of benign gastrointestinal tumors among atomic bomb survivors.
    Ron E; Wong FL; Mabuchi K
    Am J Epidemiol; 1995 Jul; 142(1):68-75. PubMed ID: 7785676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exposure to ionizing radiation and brain cancer incidence: The Life Span Study cohort.
    Smoll NR; Brady Z; Scurrah K; Mathews JD
    Cancer Epidemiol; 2016 Jun; 42():60-5. PubMed ID: 27038588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ionizing radiation exposure and the development of soft-tissue sarcomas in atomic-bomb survivors.
    Samartzis D; Nishi N; Cologne J; Funamoto S; Hayashi M; Kodama K; Miles EF; Suyama A; Soda M; Kasagi F
    J Bone Joint Surg Am; 2013 Feb; 95(3):222-9. PubMed ID: 23389785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Male Breast Cancer Incidence and Mortality Risk in the Japanese Atomic Bomb Survivors - Differences in Excess Relative and Absolute Risk from Female Breast Cancer.
    Little MP; McElvenny DM
    Environ Health Perspect; 2017 Feb; 125(2):223-229. PubMed ID: 27286002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995.
    Yonehara S; Brenner AV; Kishikawa M; Inskip PD; Preston DL; Ron E; Mabuchi K; Tokuoka S
    Cancer; 2004 Oct; 101(7):1644-54. PubMed ID: 15378499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. THYROID DISEASES AMONG ATOMIC BOMB SURVIVORS.
    Imaizumi M; Furukawa K; Ohishi W; Hida A
    Radiat Prot Dosimetry; 2018 Dec; 182(1):62-66. PubMed ID: 30165685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.